These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 38118007)

  • 41. Assessment of the pathogen genomics landscape highlights disparities and challenges for effective AMR Surveillance and outbreak response in the East African community.
    Nguinkal JA; Zoclanclounon YAB; Molina A; Roba A; Nyakio NM; Lokamar PN; Nzoyikorera N; Ihorimbere T; Nyandwi J; Aguer MA; Maror JA; Lokore ML; Francis MF; Mapunda LA; Beyanga M; Muyigi T; Pimundu G; Nabadda SN; Kabalisa E; Umuringa JD; Tare IM; Lagu HI; Achol E; May J; Affara M; Gehre F
    BMC Public Health; 2024 Jun; 24(1):1500. PubMed ID: 38840103
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Laboratory informatics capacity for effective antimicrobial resistance surveillance in resource-limited settings.
    Turner P; Rupali P; Opintan JA; Jaoko W; Feasey NA; Peacock SJ; Ashley EA
    Lancet Infect Dis; 2021 Jun; 21(6):e170-e174. PubMed ID: 33865461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial Resistance in the Asia Pacific region: a meeting report.
    Yam ELY; Hsu LY; Yap EP; Yeo TW; Lee V; Schlundt J; Lwin MO; Limmathurotsakul D; Jit M; Dedon P; Turner P; Wilder-Smith A
    Antimicrob Resist Infect Control; 2019; 8():202. PubMed ID: 31890158
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Strengthening Antimicrobial Resistance Diagnostic Capacity in Rural Rwanda: A Feasibility Assessment.
    Umutesi G; Velin L; Muwanguzi M; Faktor K; Mugabo C; Rukundo G; Rucogoza A; Yankurije M; Mazimpaka C; de Dieu Gatete J; Shyirambere C; Hedt-Gauthier B; Riviello R; Mpunga T; Mwikarago EI; Kateera F
    Ann Glob Health; 2021; 87(1):78. PubMed ID: 34430228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quality microbiological diagnostics and antimicrobial susceptibility testing, an essential component of antimicrobial resistance surveillance and control efforts in Pacific island nations.
    Ferguson JK; Joseph J; Kangapu S; Zoleveke H; Townell N; Duke T; Manning L; Lavu E
    Western Pac Surveill Response J; 2020; 11(1):41-46. PubMed ID: 32963890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Strengthening antimicrobial resistance surveillance systems: a scoping review.
    Do PC; Assefa YA; Batikawai SM; Reid SA
    BMC Infect Dis; 2023 Sep; 23(1):593. PubMed ID: 37697310
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey.
    Tomczyk S; Taylor A; Brown A; de Kraker MEA; El-Saed A; Alshamrani M; Hendriksen RS; Jacob M; Löfmark S; Perovic O; Shetty N; Sievert D; Smith R; Stelling J; Thakur S; Vietor AC; Eckmanns T;
    J Antimicrob Chemother; 2021 Oct; 76(11):3045-3058. PubMed ID: 34473285
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Global antimicrobial resistance: a system-wide comprehensive investigation using the Global One Health Index.
    Zhou N; Cheng Z; Zhang X; Lv C; Guo C; Liu H; Dong K; Zhang Y; Liu C; Chang YF; Chen S; Guo X; Zhou XN; Li M; Zhu Y
    Infect Dis Poverty; 2022 Aug; 11(1):92. PubMed ID: 35996187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Menace of antimicrobial resistance in LMICs: Current surveillance practices and control measures to tackle hostility.
    Sharma A; Singh A; Dar MA; Kaur RJ; Charan J; Iskandar K; Haque M; Murti K; Ravichandiran V; Dhingra S
    J Infect Public Health; 2022 Feb; 15(2):172-181. PubMed ID: 34972026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Supporting surveillance capacity for antimicrobial resistance: Laboratory capacity strengthening for drug resistant infections in low and middle income countries.
    Seale AC; Hutchison C; Fernandes S; Stoesser N; Kelly H; Lowe B; Turner P; Hanson K; Chandler CIR; Goodman C; Stabler RA; Scott JAG
    Wellcome Open Res; 2017; 2():91. PubMed ID: 29181453
    [TBL] [Abstract][Full Text] [Related]  

  • 51. WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study.
    Unemo M; Lahra MM; Escher M; Eremin S; Cole MJ; Galarza P; Ndowa F; Martin I; Dillon JR; Galas M; Ramon-Pardo P; Weinstock H; Wi T
    Lancet Microbe; 2021 Nov; 2(11):e627-e636. PubMed ID: 35544082
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advances in Integrated Antimicrobial Resistance Surveillance and Control Strategies in Asia-Pacific Economic Cooperation Economies: Assessment of a Multiyear Building Capacity Project.
    Cornejo J; Asenjo G; Zavala S; Venegas L; Galarce N; Hormazábal JC; Vergara-E C; Lapierre L
    Antibiotics (Basel); 2022 Jul; 11(8):. PubMed ID: 36009891
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Automating the Generation of Antimicrobial Resistance Surveillance Reports: Proof-of-Concept Study Involving Seven Hospitals in Seven Countries.
    Lim C; Miliya T; Chansamouth V; Aung MT; Karkey A; Teparrukkul P; Rahul B; Lan NPH; Stelling J; Turner P; Ashley E; van Doorn HR; Lin HN; Ling C; Hinjoy S; Iamsirithaworn S; Dunachie S; Wangrangsimakul T; Hantrakun V; Schilling W; Yen LM; Tan LV; Hlaing HH; Mayxay M; Vongsouvath M; Basnyat B; Edgeworth J; Peacock SJ; Thwaites G; Day NP; Cooper BS; Limmathurotsakul D
    J Med Internet Res; 2020 Oct; 22(10):e19762. PubMed ID: 33006570
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antimicrobial resistance in South East Asia: time to ask the right questions.
    Kakkar M; Chatterjee P; Chauhan AS; Grace D; Lindahl J; Beeche A; Jing F; Chotinan S
    Glob Health Action; 2018; 11(1):1483637. PubMed ID: 29921172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Leveraging collaborative research networks against antimicrobial resistance in Asia.
    He S; Shrestha P; Henry AD; Legido-Quigley H
    Front Public Health; 2023; 11():1191036. PubMed ID: 38146479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Whole-genome sequencing as part of national and international surveillance programmes for antimicrobial resistance: a roadmap.
    NIHR Global Health Research Unit on Genomic Surveillance of AMR
    BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33239336
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Global surveillance of antimicrobial resistance in food animals using priority drugs maps.
    Zhao C; Wang Y; Mulchandani R; Van Boeckel TP
    Nat Commun; 2024 Jan; 15(1):763. PubMed ID: 38278814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Japan nosocomial infections surveillance (JANIS): a model of sustainable national antimicrobial resistance surveillance based on hospital diagnostic microbiology laboratories.
    Tsutsui A; Suzuki S
    BMC Health Serv Res; 2018 Oct; 18(1):799. PubMed ID: 30342499
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unbiased antimicrobial resistance prevalence estimates through population-based surveillance.
    van Leth F; Schultsz C
    Clin Microbiol Infect; 2023 Apr; 29(4):429-433. PubMed ID: 35595126
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Generalizability of machine learning in predicting antimicrobial resistance in E. coli: a multi-country case study in Africa.
    Nsubuga M; Galiwango R; Jjingo D; Mboowa G
    BMC Genomics; 2024 Mar; 25(1):287. PubMed ID: 38500034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.